New York, July 11, 2017 /Financeswire/: Market Research Engine has published a new report titled as “Healthcare Biomarkers Market By Product Analysis (Consumable, Software, Services); By Type Analysis (Safety biomarker, Validation biomarker, Efficacy biomarker); By Application Analysis (Diagnostics development, Personalized medicine, Drug discovery & development, Disease risk assessment); By Disease indication Analysis (Cancer, Neurological disorders, Cardiovascular disorders, Immunological disorders) and By Regional Analysis – Global Forecast by 2016 – 2022”

    A biomarker refers to a biological molecule or gene that is used to efficiently and correctly evaluate pharmacologic reHealthcare Biomarkers Marketsponses, pathogenic approaches, and biological tactics. Also known as a molecular marker or signature molecule, biomarkers are located in blood, different frame fluids, and tissue. Drastically used to peer the frame’s response to a selected remedy for a disease or condition, biomarkers assist clinical specialists to take powerful clinical decisions and help in diagnosing the fitness of patients. The U.S. food and drug management has approved the usage of biomarkers as surrogate quit-factors in the remedy improvement process. Biomarkers play a pivotal role in ailment danger assessment, drug discovery and improvement, diagnostics improvement, personalized medicinal drug, and others. Research activities are especially focused on the development of diagnostics biomarkers for most cancers.

    Browse Full Report: https://www.marketresearchengine.com/reportdetails/healthcare-biomarkers-market

    The Global Healthcare Biomarkers Market is expected to exceed more than US$ 56 billion by 2022 and will grow at a CAGR of more than 13% in the given forecast period.

    The major driving factors of Global Healthcare Biomarkers Market are as follows:

    •    Rise in number of cros and low down cost for conduct clinical trials in developing nations.
    •    Use of biomarkers in diagnostic procedure is enhancing rapidly.
    •    Increasing healthcare expenses and R&D funding.

    The restraining factors of Global Healthcare Biomarkers Market are as follows:

    •    Technological issue associated to sample and storage.
    •    High investment and low cost and benefit ratio.
    •    High testing cost

    The Global Healthcare Biomarkers Market is segmented on the lines of its product, type, application, disease indication and regional. Based on product segmentation it covers consumable, software and services. Type segmentation covers safety biomarker, validation biomarker and efficacy biomarker. The applications segmentation contains diagnostics development, personalized medicine, drug discovery & development and disease risk assessment. Under disease indication segmentation it covers cancer, neurological disorders, cardiovascular disorders and immunological disorders. The Global Healthcare Biomarkers Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

    REPORT SCOPE:

    The scope of the report includes a detailed study of global and regional markets for Global Healthcare Biomarkers Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche Diagnostics Ltd., Abbott Laboratories, Inc., Agilent Technologies, Inc., Epigenomics AG, GE Healthcare, Johnson & Johnson, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH, Qiagen N.V., and Merck& Co., Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.

    The Global Healthcare Biomarkers Market has been segmented as below:

    By Product Analysis

    •    Consumable
    •    Software
    •    Services

    By Type Analysis

    •    Safety biomarker
    •    Validation biomarker
    •    Efficacy biomarker

    By Application Analysis

    •    Diagnostics development
    •    Personalized medicine
    •    Drug discovery & development
    •    Disease risk assessment

    By Disease indication Analysis

    •    Cancer
    •    Neurological disorders
    •    Cardiovascular disorders
    •    Immunological disorders

    By Regional Analysis

    •    North America
    •    Europe
    •    Asia-Pacific
    •    Rest of the World

     

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

    Source: http://www.financeswire.com/healthcare-biomarkers-market-to-reach-us-56-billion-by-2022